Even though GLP-1 agonists are safe and effective in children, there may be practical, economic and ethical challenges to pharmacological weight management in childhood
GLP focuses on pre-clinical studies, G(C)LP focuses on laboratory testing under GMP, and GCP governs clinical trials involving humans
has consulted for or received lecture fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Hanmi Pharmaceuticals, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer and Sanofi and received grant support from AstraZeneca, Boehringer Ingelheim, Novartis and Roche Diagnostics through his institution, the University of Glasgow
Duis cursus, mi quis viverra ornare